This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Letairis (Ambrisentan) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (5393)
Death (1479)
Life Threatening Events (50)
Disability (26)
Reports by Reaction Type
Death (940),
Dyspnoea (707),
Pneumonia (555),
Unevaluable Event (248),
Fluid Retention (184),
Cardiac Failure Congestive (182),
Pulmonary Arterial Hypertension (181),
Syncope (171),
Chest Pain (150),
Fall (135),
Oedema (114),
Hypotension (114)
Below are a few examples of reports where side effects / adverse reactions may be related to Letairis (Ambrisentan). For a complete list or a specific selection of reports, please use the links above.
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dyspnoea, Cystitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Chills, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2010-07-02
Letairis
Indication: Scleroderma
Other drugs received by patient: Tyvaso
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Renal Disorder, Pulmonary Arterial Hypertension
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Pneumonia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Indication: Pulmonary Fibrosis
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-06-16
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Balance Disorder, Vertigo
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Tyvaso; Adcirca
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Dyspnoea, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Right Ventricular Failure, Cardio-Respiratory Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Indication: Sleep Apnoea Syndrome
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2007-10-04
End date: 2012-07-01
Other drugs received by patient: Oxygen
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Breast Lump Removal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Heart Transplant
Drug(s) suspected as cause:
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Letairis
Indication: Heart Disease Congenital
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Pneumonia, Swelling
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Indication: Connective Tissue Disorder
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-05-29
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Respiratory Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Catheterisation Cardiac
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Pyrexia, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Pulmonary Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Bronchitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Pulmonary Arterial Hypertension, Device Malfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Other drugs received by patient: Tyvaso
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female
Reactions: Syncope
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in female
Reported by a physician from United States on 2012-08-24
Patient: female
Reactions: Localised Infection, Limb Traumatic Amputation
Drug(s) suspected as cause:
Letairis
Indication: Crest Syndrome
Letairis
Dosage: 10 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2009-04-06
Letairis
Indication: Scleroderma
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Letairis
Indication: Scleroderma
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2010-04-28
End date: 2012-07-19
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female
Reactions: Fatigue, Stent Placement, Oxygen Saturation Decreased, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Possible Letairis side effects in 60 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 60 year old female
Reactions: Interstitial Lung Disease
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Letairis
Dosage: 2.5mg per day
Administration route: Oral
Start date: 2011-05-17
End date: 2011-05-23
Letairis
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-17
End date: 2011-05-23
Other drugs received by patient: Alfarol; Aldactone; Gasmotin; Mucosta; Calcium Carbonate; Paxil; Alfarol; Sulfamethoxazole and Trimethoprim; Zolpidem; Furosemide; Aspartic Acid; Warfarin Sodium; Neoral; Paxil; Rabeprazole Sodium; Alfarol; Zolpidem; Furosemide; Furosemide; Maglax; Maglax; Gasmotin; Potassium Magnesium Aspartate; Rabeprazole Sodium; Sulfamethoxazole and Trimethoprim; Aldactone; Aspara K; Warfarin Sodium; Warfarin Sodium; Gasmotin; Amoban; Amoban; Neoral; Mucosta; Mucosta; Calcium Carbonate; Fungizone; Fungizone; Sulfamethoxazole and Trimethoprim; Neoral; Calcium Carbonate; Amoban; Aldactone; Cyclosporine; Paxil; Fungizone; Rabeprazole Sodium; Zolpidem; Maglax
Possible Letairis side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female
Reactions: Pneumonia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letairis
Indication: HIV Infection
Letairis
Dosage: 5 mg, unk
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2012-07-19
Possible Letairis side effects in 60 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 60 year old female
Reactions: Interstitial Lung Disease
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Letairis
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-17
End date: 2011-05-23
Letairis
Dosage: 2.5mg per day
Administration route: Oral
Start date: 2011-05-17
End date: 2011-05-23
Other drugs received by patient: Mucosta; Calcium Carbonate; Amoban; Paxil; Zolpidem; Zolpidem; Warfarin Sodium; Sulfamethoxazole and Trimethoprim; Zolpidem; Furosemide; Aspartic Acid; Aspara K; Gasmotin; Mucosta; Mucosta; Calcium Carbonate; Paxil; Fungizone; Furosemide; Cyclosporine; Neoral; Calcium Carbonate; Amoban; Maglax; Warfarin Sodium; Potassium Magnesium Aspartate; Paxil; Fungizone; Alfarol; Alfarol; Aldactone; Furosemide; Maglax; Maglax; Warfarin Sodium; Fungizone; Alfarol; Sulfamethoxazole and Trimethoprim; Aldactone; Neoral; Neoral; Rabeprazole Sodium; Gasmotin; Gasmotin; Amoban; Rabeprazole Sodium; Rabeprazole Sodium; Sulfamethoxazole and Trimethoprim; Aldactone
|